Combination of Infliximab and High-Dose Intravenous Immunoglobulin for Toxic Epidermal Necrolysis: Successful Treatment of an Elderly Patient

• Главные авторы: Konstantinos Patmanidis (Автор), Anastasios Sidiras (Автор), Konstantinos Dolianitis (Автор), Dimitrios Simelidis (Автор), Christos Solomonidis (Автор), Georgios Gaitanis (Автор), Ioannis D. Bassukas (Автор)
• Формат: ‌
• Опубликовано: Hindawi Limited, 2012-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Toxic epidermal necrolysis (TEN) is a rare, severe cutaneous adverse drug reaction with average mortality 25-35%, especially among elderly multimorbid patients. Established therapeutic guidelines do not exist and controversies underlie many of the presently suggested treatment regimens. Herein we pr...